Drug Profile
Ulobetasol lotion - Sun Pharmaceutical Industries
Alternative Names: Halobetasol propionate lotion- Sun Pharmaceutical Industries; HBP lotion- Sun Pharmaceutical Industries; UltravateLatest Information Update: 22 Oct 2020
Price :
$50
*
At a glance
- Originator Sun Pharmaceutical Industries
- Class Anti-inflammatories; Antiallergics; Antipsoriatics; Corticosteroids; Skin disorder therapies; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Plaque psoriasis
- No development reported Atopic dermatitis
Most Recent Events
- 22 Oct 2020 No development reported - Phase-II for Atopic dermatitis (In adolescents, In children, In the elderly, In adults) in USA (Topical)
- 09 May 2018 Sun Pharmaceutical Industries and MiCal Pharmaceuticals initiates litigation against Perrigo Company over ANDA submission in USA
- 15 Feb 2018 Sun Pharmaceutical Industries Limited suspends patient enrolment in a phase II trial due to sponsor's decision in Atopic dermatitis (In children, In adolescents, In adults, In the elderly) in USA (Topical, Spray) (NCT03245385)